Ashkan Shoamanesh
@ash-shoamanesh.bsky.social
Stroke Neurologist at Hamilton Health Sciences
Associate Professor of Medicine (Div. of Neurology) at McMaster University
Director of Hemorrhagic Stroke Research Program & Senior Scientist at the Population Health Research Institute
Associate Professor of Medicine (Div. of Neurology) at McMaster University
Director of Hemorrhagic Stroke Research Program & Senior Scientist at the Population Health Research Institute
Pinned
Thrilled to share that the OCEANIC-STROKE trial (NCT05686070) led by PHRI & Bayer AG, has successfully completed enrolment of over 12,300 participants with non-cardioembolic ischemic #stroke over a recruitment period of only 26-months!
🔗https://phri.ca/oceanicstroke/
🔗https://phri.ca/oceanicstroke/
We are absolutely thrilled to share that the OCEANIC-STROKE trial has successfully met its primary efficacy & safety endpoints.
These landmark findings address a major unmet need in the ~5M people worldwide who have a new non-cardioembolic ischemic stroke each year.
www.bayer.com/media/en-us/...
These landmark findings address a major unmet need in the ~5M people worldwide who have a new non-cardioembolic ischemic stroke each year.
www.bayer.com/media/en-us/...
www.bayer.com
November 24, 2025 at 2:31 AM
We are absolutely thrilled to share that the OCEANIC-STROKE trial has successfully met its primary efficacy & safety endpoints.
These landmark findings address a major unmet need in the ~5M people worldwide who have a new non-cardioembolic ischemic stroke each year.
www.bayer.com/media/en-us/...
These landmark findings address a major unmet need in the ~5M people worldwide who have a new non-cardioembolic ischemic stroke each year.
www.bayer.com/media/en-us/...
Reposted by Ashkan Shoamanesh
Proudly sharing our publication featured in NY Times: 17 Ways to Cut Your Risk of Stroke, Dementia and Depression All at Once www.nytimes.com/2025/04/23/w...
17 Ways to Cut Your Risk of Stroke, Dementia and Depression All at Once
A new study identified overlapping factors that affect your odds of developing these brain diseases late in life.
www.nytimes.com
April 24, 2025 at 11:32 AM
Proudly sharing our publication featured in NY Times: 17 Ways to Cut Your Risk of Stroke, Dementia and Depression All at Once www.nytimes.com/2025/04/23/w...
Reposted by Ashkan Shoamanesh
High lipoprotein(a) levels, defined as 50 mg/dL or greater, are associated with increased rates of atherosclerotic cardiovascular disease events and all-cause mortality. This JAMA Insights discusses lipoprotein(a).
#MedSky https://ja.ma/42Ma9Wv
#MedSky https://ja.ma/42Ma9Wv
Lipoprotein(a)
This JAMA Insights discusses lipoprotein(a), including factors associated with elevated lipoprotein(a) levels, how to manage them, and atherosclerotic cardiovascular disease risk.
ja.ma
April 24, 2025 at 4:00 PM
High lipoprotein(a) levels, defined as 50 mg/dL or greater, are associated with increased rates of atherosclerotic cardiovascular disease events and all-cause mortality. This JAMA Insights discusses lipoprotein(a).
#MedSky https://ja.ma/42Ma9Wv
#MedSky https://ja.ma/42Ma9Wv
Reposted by Ashkan Shoamanesh
Exciting News!
🚨 Save the Date for the 2026 Canadian Stroke Congress
🗻 Banff, Alberta
📅 May 23-26, 2026
More details coming soon at www.CanadianStroke.ca
#CSC2026 #StrokeCongress26 #SavetheDate #StrokeRecovery #StrokeResearch
🚨 Save the Date for the 2026 Canadian Stroke Congress
🗻 Banff, Alberta
📅 May 23-26, 2026
More details coming soon at www.CanadianStroke.ca
#CSC2026 #StrokeCongress26 #SavetheDate #StrokeRecovery #StrokeResearch
April 24, 2025 at 4:16 PM
Exciting News!
🚨 Save the Date for the 2026 Canadian Stroke Congress
🗻 Banff, Alberta
📅 May 23-26, 2026
More details coming soon at www.CanadianStroke.ca
#CSC2026 #StrokeCongress26 #SavetheDate #StrokeRecovery #StrokeResearch
🚨 Save the Date for the 2026 Canadian Stroke Congress
🗻 Banff, Alberta
📅 May 23-26, 2026
More details coming soon at www.CanadianStroke.ca
#CSC2026 #StrokeCongress26 #SavetheDate #StrokeRecovery #StrokeResearch
The ICH-ADAPT2 trial results were just published in
@jama.com Neurology. DWI lesions are observed in ~33% of patients with acute ICH. Our findings do not support a causal relationship between intensive BP lowering and DWI lesions in these patients.
jamanetwork.com/journals/jam...
@jama.com Neurology. DWI lesions are observed in ~33% of patients with acute ICH. Our findings do not support a causal relationship between intensive BP lowering and DWI lesions in these patients.
jamanetwork.com/journals/jam...
Blood Pressure Lowering and Risk of Ischemic Lesions After Intracerebral Hemorrhage
This multicenter, randomized clinical trial examines whether systolic blood pressure reduction increases the incidence of lesions detected with diffusion-weighted imaging in adult patients with acute ...
jamanetwork.com
April 23, 2025 at 11:37 PM
The ICH-ADAPT2 trial results were just published in
@jama.com Neurology. DWI lesions are observed in ~33% of patients with acute ICH. Our findings do not support a causal relationship between intensive BP lowering and DWI lesions in these patients.
jamanetwork.com/journals/jam...
@jama.com Neurology. DWI lesions are observed in ~33% of patients with acute ICH. Our findings do not support a causal relationship between intensive BP lowering and DWI lesions in these patients.
jamanetwork.com/journals/jam...
Thrilled to share that the OCEANIC-STROKE trial (NCT05686070) led by PHRI & Bayer AG, has successfully completed enrolment of over 12,300 participants with non-cardioembolic ischemic #stroke over a recruitment period of only 26-months!
🔗https://phri.ca/oceanicstroke/
🔗https://phri.ca/oceanicstroke/
April 23, 2025 at 11:35 PM
Thrilled to share that the OCEANIC-STROKE trial (NCT05686070) led by PHRI & Bayer AG, has successfully completed enrolment of over 12,300 participants with non-cardioembolic ischemic #stroke over a recruitment period of only 26-months!
🔗https://phri.ca/oceanicstroke/
🔗https://phri.ca/oceanicstroke/
For those interested and who were unable to join us at @americanheart.bsky.social #ISC2025 please find the recording of our @medscape.com webinar on the rise of new anticoagulants for stroke prevention here:
www.youtube.com/watch?v=D8f0...
@macdeptmed.bsky.social
www.youtube.com/watch?v=D8f0...
@macdeptmed.bsky.social
Staying Ahead in Stroke Prevention: The Rise of New Anticoagulation Approaches
YouTube video by Medscape
www.youtube.com
March 8, 2025 at 4:19 AM
For those interested and who were unable to join us at @americanheart.bsky.social #ISC2025 please find the recording of our @medscape.com webinar on the rise of new anticoagulants for stroke prevention here:
www.youtube.com/watch?v=D8f0...
@macdeptmed.bsky.social
www.youtube.com/watch?v=D8f0...
@macdeptmed.bsky.social
Absolutely honoured to be delivering the inaugural Ralph Sacco Distinguished Lecture at the @universityofmiami.bsky.social 58th Neurology Update & Stroke Intensive Review. Huge thanks to Drs. Negar Asdaghi & Jose Romano for their generous invitation and gracious hospitality!
@macdeptmed.bsky.social
@macdeptmed.bsky.social
March 8, 2025 at 4:16 AM
Absolutely honoured to be delivering the inaugural Ralph Sacco Distinguished Lecture at the @universityofmiami.bsky.social 58th Neurology Update & Stroke Intensive Review. Huge thanks to Drs. Negar Asdaghi & Jose Romano for their generous invitation and gracious hospitality!
@macdeptmed.bsky.social
@macdeptmed.bsky.social
Congrats to Ken Butcher on successfully leading the ICH-ADAPT 2 RCT. Our results do not support the notion that BP lowering contributes to the majority of acute/subacute DWI lesions in patients with ICH. Alternative mechanisms need to be explored. #ISC2025
@ahascience.bsky.social
@ahascience.bsky.social
February 9, 2025 at 7:09 PM
Congrats to Ken Butcher on successfully leading the ICH-ADAPT 2 RCT. Our results do not support the notion that BP lowering contributes to the majority of acute/subacute DWI lesions in patients with ICH. Alternative mechanisms need to be explored. #ISC2025
@ahascience.bsky.social
@ahascience.bsky.social
For those who were unable to attend our update on best practices for managing ICH at #ISC2025, you can find the recording below:
www.youtube.com/watch?v=PiCn...
@christoslazaridis.bsky.social
www.youtube.com/watch?v=PiCn...
@christoslazaridis.bsky.social
CME at ISC 2025 - Best Practices for Managing Intracerebral Hemorrhage
YouTube video by CMEPlanet
www.youtube.com
February 9, 2025 at 6:52 PM
For those who were unable to attend our update on best practices for managing ICH at #ISC2025, you can find the recording below:
www.youtube.com/watch?v=PiCn...
@christoslazaridis.bsky.social
www.youtube.com/watch?v=PiCn...
@christoslazaridis.bsky.social
Reposted by Ashkan Shoamanesh
February 6, 2025 at 7:32 PM
Should patients with #stroke and device-detected subclinical #AFib (SCAF) be treated with OAC?
Our subgroup analyses of the ARTESIA RCT (@thelancet.bsky.social) provide novel insights indicating that OAC is beneficial in appropriately selected patients.
www.thelancet.com/journals/lan...
Our subgroup analyses of the ARTESIA RCT (@thelancet.bsky.social) provide novel insights indicating that OAC is beneficial in appropriately selected patients.
www.thelancet.com/journals/lan...
January 23, 2025 at 4:16 AM
Should patients with #stroke and device-detected subclinical #AFib (SCAF) be treated with OAC?
Our subgroup analyses of the ARTESIA RCT (@thelancet.bsky.social) provide novel insights indicating that OAC is beneficial in appropriately selected patients.
www.thelancet.com/journals/lan...
Our subgroup analyses of the ARTESIA RCT (@thelancet.bsky.social) provide novel insights indicating that OAC is beneficial in appropriately selected patients.
www.thelancet.com/journals/lan...
January 18, 2025 at 9:50 PM
Congratulation to Dr. Sashi Perera on leading this important phase II RCT suggesting reduced rates of ischemic cerebrovascular events with dual pathway inhibition (rivaroxaban+ASA) in patients with ICAD.
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @ahascience.bsky.social
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @ahascience.bsky.social
Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease | Stroke
BACKGROUND: Stroke secondary to intracranial atherosclerotic disease (ICAD) is associated with
high recurrence risk despite currently available secondary prevention strategies.
In patients with system...
www.ahajournals.org
January 16, 2025 at 1:42 AM
Congratulation to Dr. Sashi Perera on leading this important phase II RCT suggesting reduced rates of ischemic cerebrovascular events with dual pathway inhibition (rivaroxaban+ASA) in patients with ICAD.
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @ahascience.bsky.social
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @ahascience.bsky.social
Thrilled to announce that the #EnrichAF randomized trial completed enrolment of 948 patients in Q4 2024.
So grateful for the efforts of our global colleagues on reaching this milestone, who persevered despite many challenges along the way.
Follow-up is due to complete in Q1 2026. Stay tuned!
So grateful for the efforts of our global colleagues on reaching this milestone, who persevered despite many challenges along the way.
Follow-up is due to complete in Q1 2026. Stay tuned!
January 16, 2025 at 1:38 AM
Thrilled to announce that the #EnrichAF randomized trial completed enrolment of 948 patients in Q4 2024.
So grateful for the efforts of our global colleagues on reaching this milestone, who persevered despite many challenges along the way.
Follow-up is due to complete in Q1 2026. Stay tuned!
So grateful for the efforts of our global colleagues on reaching this milestone, who persevered despite many challenges along the way.
Follow-up is due to complete in Q1 2026. Stay tuned!
See our recent @worldstrokeorg.bsky.social scientific statement on secondary #stroke prevention in patients w #Afib. Big thanks Dr. Luciano Sposato for taking on the lion's share of work for this important piece.
@macdeptmed.bsky.social
journals.sagepub.com/doi/10.1177/...
@macdeptmed.bsky.social
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com
December 31, 2024 at 4:47 PM
See our recent @worldstrokeorg.bsky.social scientific statement on secondary #stroke prevention in patients w #Afib. Big thanks Dr. Luciano Sposato for taking on the lion's share of work for this important piece.
@macdeptmed.bsky.social
journals.sagepub.com/doi/10.1177/...
@macdeptmed.bsky.social
journals.sagepub.com/doi/10.1177/...
Reposted by Ashkan Shoamanesh
🎉 Exciting News! 🎉
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
December 18, 2024 at 5:24 PM
🎉 Exciting News! 🎉
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
Kudos to Dr. Lauren Mai from @westernu.bsky.social
on leading this insightful narrative review outlining the protracted recovery trajectory of patients with ICH.
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @harvardmed.bsky.social @ahajournals.bsky.social @ahascience.bsky.social
on leading this insightful narrative review outlining the protracted recovery trajectory of patients with ICH.
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @harvardmed.bsky.social @ahajournals.bsky.social @ahascience.bsky.social
American Heart Association Journals
www.ahajournals.org
December 18, 2024 at 2:43 PM
Kudos to Dr. Lauren Mai from @westernu.bsky.social
on leading this insightful narrative review outlining the protracted recovery trajectory of patients with ICH.
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @harvardmed.bsky.social @ahajournals.bsky.social @ahascience.bsky.social
on leading this insightful narrative review outlining the protracted recovery trajectory of patients with ICH.
www.ahajournals.org/doi/10.1161/...
@macdeptmed.bsky.social @harvardmed.bsky.social @ahajournals.bsky.social @ahascience.bsky.social